Subject(s)
Humans , Male , Aged , Chylous Ascites , Lymphoma, Large B-Cell, Diffuse , Hypertension , Ultrasonography , Gastrointestinal Diseases , GastroenterologyABSTRACT
No disponible
Subject(s)
Humans , Female , Adult , Aged , Eosinophilia/complications , Gastroenteritis/complications , Laparoscopy , Adrenal Cortex Hormones/therapeutic useSubject(s)
Enteritis/diagnosis , Eosinophilia/diagnosis , Gastritis/diagnosis , Adrenal Cortex Hormones/therapeutic use , Adult , Aged , Biopsy , Early Diagnosis , Enteritis/diagnostic imaging , Enteritis/drug therapy , Eosinophilia/diagnostic imaging , Eosinophilia/drug therapy , Female , Gastritis/diagnostic imaging , Gastritis/drug therapy , Gastroscopy , Humans , Male , Middle Aged , Recurrence , Tomography, X-Ray Computed , UltrasonographyABSTRACT
No disponible
Subject(s)
Humans , Female , Aged , Pyloric Stenosis, Hypertrophic/diagnosis , Gastrectomy , Abdomen, Acute/etiology , Asymptomatic DiseasesABSTRACT
No disponible
Subject(s)
Humans , Male , Aged , Celiac Disease/chemically induced , Celiac Disease/complications , Celiac Disease/diagnosis , Olmesartan Medoxomil/adverse effects , Olmesartan Medoxomil/therapeutic use , Hypertension/complications , Hypertension/drug therapy , Hypoalbuminemia/complications , Hypokalemia/complications , Colonoscopy , Gastroscopy/methodsSubject(s)
Gastric Dilatation/etiology , Pyloric Stenosis, Hypertrophic/complications , Aged , Emergencies , Esophagoplasty , Female , Gastrectomy , Gastric Dilatation/surgery , Humans , Jejunostomy , Pneumoperitoneum/etiology , Pyloric Stenosis, Hypertrophic/diagnostic imaging , Pyloric Stenosis, Hypertrophic/surgeryABSTRACT
Olmesartan is a therapy used for the management of hypertension available since 2002. A sprue like enteropathy associated with olmesartan has been first described in 2012. Endoscopic and histopathological findings are partial or total villous atrophy, mimicking a Celiac Disease. We explain two cases diagnosed in our hospital. Both patients took more than one year of treatment with olmesartan. In both cases, the biopsy showed duodenal villous atrophy, negative serology for celiac disease and they improved after stopping treatment with olmesartan. Olmesartan associate sprue-like enteropathy should be included in the differential diagnosis of seronegative villous atrophy. After the discontinuation of olmesartan, clinical remission usually occurs in every patients.